Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118709339 | 11870933 | 9 | F | 20160509 | 20160624 | 20151228 | 20160701 | EXP | PHHY2015GB164836 | SANDOZ | 53.00 | YR | F | Y | 0.00000 | 20160701 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118709339 | 11870933 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | UNK | U | 76959 | |||||||||
| 118709339 | 11870933 | 2 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Unknown | CYCLE 10 | U | 76959 | |||||||||
| 118709339 | 11870933 | 3 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 118709339 | 11870933 | 4 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
| 118709339 | 11870933 | 5 | SS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Unknown | CYCLE 10 | U | 0 | |||||||||
| 118709339 | 11870933 | 6 | SS | CHLORHEXIDINE | CHLORHEXIDINE | 1 | Unknown | U | 0 | ||||||||||
| 118709339 | 11870933 | 7 | SS | CHLORHEXIDINE | CHLORHEXIDINE | 1 | Unknown | U | 0 | ||||||||||
| 118709339 | 11870933 | 8 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Subcutaneous | 600 MG | U | 0 | 600 | MG | |||||||
| 118709339 | 11870933 | 9 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Subcutaneous | U | 0 | ||||||||||
| 118709339 | 11870933 | 10 | SS | HERCEPTIN | TRASTUZUMAB | 1 | Subcutaneous | U | 0 | 600 | MG | ||||||||
| 118709339 | 11870933 | 11 | C | VINORELBINE | VINORELBINEVINORELBINE TARTRATE | 1 | Oral | U | 0 | ||||||||||
| 118709339 | 11870933 | 12 | C | VINORELBINE | VINORELBINEVINORELBINE TARTRATE | 1 | Oral | U | 0 | ||||||||||
| 118709339 | 11870933 | 13 | C | VINORELBINE | VINORELBINEVINORELBINE TARTRATE | 1 | Oral | U | 0 | ||||||||||
| 118709339 | 11870933 | 14 | C | VINORELBINE | VINORELBINEVINORELBINE TARTRATE | 1 | Oral | U | 0 | ||||||||||
| 118709339 | 11870933 | 15 | C | VINORELBINE | VINORELBINEVINORELBINE TARTRATE | 1 | Oral | U | 0 | ||||||||||
| 118709339 | 11870933 | 16 | C | VINORELBINE | VINORELBINEVINORELBINE TARTRATE | 1 | Oral | U | 0 | ||||||||||
| 118709339 | 11870933 | 17 | C | GRANISETRON | GRANISETRON | 1 | Unknown | U | 0 | ||||||||||
| 118709339 | 11870933 | 18 | C | GRANISETRON | GRANISETRON | 1 | Unknown | U | 0 | ||||||||||
| 118709339 | 11870933 | 19 | C | NEULASTA | PEGFILGRASTIM | 1 | Unknown | U | 0 | ||||||||||
| 118709339 | 11870933 | 20 | C | NEULASTA | PEGFILGRASTIM | 1 | Unknown | U | 0 | ||||||||||
| 118709339 | 11870933 | 21 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118709339 | 11870933 | 1 | Product used for unknown indication |
| 118709339 | 11870933 | 3 | Product used for unknown indication |
| 118709339 | 11870933 | 6 | Product used for unknown indication |
| 118709339 | 11870933 | 8 | Product used for unknown indication |
| 118709339 | 11870933 | 11 | Product used for unknown indication |
| 118709339 | 11870933 | 17 | Product used for unknown indication |
| 118709339 | 11870933 | 19 | Product used for unknown indication |
| 118709339 | 11870933 | 21 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118709339 | 11870933 | HO |
| 118709339 | 11870933 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118709339 | 11870933 | Allergy to chemicals | |
| 118709339 | 11870933 | Anaemia | |
| 118709339 | 11870933 | Blood creatinine increased | |
| 118709339 | 11870933 | Breast cancer metastatic | |
| 118709339 | 11870933 | Constipation | |
| 118709339 | 11870933 | Cough | |
| 118709339 | 11870933 | Diarrhoea | |
| 118709339 | 11870933 | Dysgeusia | |
| 118709339 | 11870933 | Dysphonia | |
| 118709339 | 11870933 | Fatigue | |
| 118709339 | 11870933 | Haemoglobin decreased | |
| 118709339 | 11870933 | Hyperaesthesia | |
| 118709339 | 11870933 | Hypokinesia | |
| 118709339 | 11870933 | Limb discomfort | |
| 118709339 | 11870933 | Lymphoedema | |
| 118709339 | 11870933 | Musculoskeletal disorder | |
| 118709339 | 11870933 | Nausea | |
| 118709339 | 11870933 | Neuralgia | |
| 118709339 | 11870933 | Neuropathy peripheral | |
| 118709339 | 11870933 | Oedema | |
| 118709339 | 11870933 | Pain in extremity | |
| 118709339 | 11870933 | Paraesthesia | |
| 118709339 | 11870933 | Pyrexia | |
| 118709339 | 11870933 | Rhinorrhoea | |
| 118709339 | 11870933 | Sensory loss | |
| 118709339 | 11870933 | Vomiting | |
| 118709339 | 11870933 | Wound | |
| 118709339 | 11870933 | Wound haemorrhage | |
| 118709339 | 11870933 | Wound secretion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |